Baxter International Inc. (BAX) to Issue Quarterly Dividend of $0.01 on April 1st

Baxter International Inc. (NYSE:BAX) declared a quarterly dividend on Wednesday, February 11th. Investors of record on Friday, February 27th will be given a dividend of 0.01 per share by the medical instruments supplier on Wednesday, April 1st. This represents a c) annualized dividend and a yield of 0.2%. The ex-dividend date is Friday, February 27th.

Baxter International has decreased its dividend payment by an average of 0.1%per year over the last three years. Baxter International has a dividend payout ratio of 1.5% indicating that its dividend is sufficiently covered by earnings. Analysts expect Baxter International to earn $2.73 per share next year, which means the company should continue to be able to cover its $0.04 annual dividend with an expected future payout ratio of 1.5%.

Baxter International Stock Performance

Shares of BAX opened at $20.63 on Wednesday. The business has a 50-day simple moving average of $20.11 and a two-hundred day simple moving average of $21.08. The company has a quick ratio of 1.56, a current ratio of 2.31 and a debt-to-equity ratio of 1.55. Baxter International has a 52 week low of $17.40 and a 52 week high of $37.74. The stock has a market cap of $10.61 billion, a price-to-earnings ratio of -11.15, a PEG ratio of 1.48 and a beta of 0.59.

Baxter International (NYSE:BAX) last posted its quarterly earnings data on Thursday, February 12th. The medical instruments supplier reported $0.44 earnings per share for the quarter, missing analysts’ consensus estimates of $0.53 by ($0.09). The company had revenue of $2.97 billion for the quarter, compared to analysts’ expectations of $2.82 billion. Baxter International had a negative net margin of 8.51% and a positive return on equity of 16.95%. The firm’s quarterly revenue was up 8.0% on a year-over-year basis. During the same period in the previous year, the firm earned $0.58 earnings per share. Baxter International has set its FY 2026 guidance at 1.850-2.050 EPS. On average, analysts expect that Baxter International will post 2.48 EPS for the current year.

About Baxter International

Baxter International Inc is a global healthcare company that develops, manufactures and markets a broad portfolio of medical products, pharmaceutical therapies and biotechnology-based solutions. The company’s primary business activities are organized around renal care, medication delivery, acute therapies, pharmacy automation, surgical care and biotechnology. Baxter’s offerings are designed to support patient care in hospitals, dialysis centers, nursing homes and other healthcare facilities worldwide.

In the renal care segment, Baxter provides hemodialysis and peritoneal dialysis systems, water treatment equipment and related disposables, including dialyzers, bloodlines and catheters.